Brief: G1 Therapeutics Provides Third Quarter 2022 Financial Results And Operational Highlights

G1 Therapeutics

02/11/2022 10:56

Nov 2 (Reuters) - G1 Therapeutics Inc  GTHX.O :
    * G1 THERAPEUTICS PROVIDES THIRD QUARTER 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * Q3 REVENUE $23.6 MILLION VERSUS $4.9 MILLION
    * ACHIEVED $23.6 MILLION IN TOTAL REVENUE IN Q3 OF 2022
INCLUDING
$8.3 MILLION IN NET REVENUE FROM SALES OF COSELA
    * QTRLY LOSS PER SHARE $0.59
    * Q3 EARNINGS PER SHARE VIEW $-0.63, REVENUE VIEW $23.3
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX42j4Ng 
Further company coverage:  GTHX.O 
 ((Reuters.Briefs@thomsonreuters.com;))